Arcellx
Arcellx is a Maryland-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Arcellx Information
Geographic Data
Address: 25 West Watkins Mill Road
City: Gaithersburg
State: MD
Zip: 20878
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$112M
Raised Total:$207M
Social
Metrics
1,692,246Website Global Rank
13,876Website Monthly Traffic
Twitter Followers
Description
Arcellx is a Maryland-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases.
Contact Phone:
+12403270603
Contact Email:
Arcellx went public on 2/4/2022 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/4/2022
IPO Valuation:
$503M
Ticker Symbol:
ACLX
IPO Price:
$15/share
Amount Raised:
$124M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
